Leaderboards/dialysis and renal disease management

dialysis and renal disease management

Last updated June 11, 2026

Rising Stars

New and hot

Rising Stars Researchers

1
Quinn Rafferty
Institute for Health Metrics and Evaluation
99
2
On Ying Angela Lee
Hong Kong Polytechnic University
90
3
Martin Ho Yin Yeung
Hong Kong Polytechnic University
80
4
Antonis Fanouriakis
National and Kapodistrian University of Athens
70
5
Norio Hanafusa
Nihon University
50
6
Fei‐Yuan Hsiao
National Taiwan University Hospital
40
7
Liang‐Kung Chen
Taipei Veterans General Hospital
30
8
Lucy Selman
University of Bristol
20
9
Dan‐Qian Chen
Northwest University
10

Rising Stars Papers

Insufficient data

Emerging Leaders

Gaining momentum

Emerging Leaders Researchers

1
Adeera Levin
Providence Health Care
99
2
Rajesh Kumar Jha
Unknown
90
3
Valérie A. Luyckx
Brigham and Women's Hospital
70
4
Pieter Evenepoel
KU Leuven
60
5
Jürgen Floege
Westfälische Hochschule
50
6
Hailing Zhao
China-Japan Friendship Hospital
40
7
Suguru Yamamoto
Niigata University
30
8
Saira Amir
Johns Hopkins University
20
9
Klaudia Kitala–Tańska
Medical University of Silesia
10

Emerging Leaders Papers

1
Impact of the COVID-19 pandemic on the kidney community: lessons learned and future directions
Nature Reviews Nephrology|2022
91 cit.

All-Time Leaders

The canon

All-Time Leaders Researchers

1
Josephine P. Briggs
Tufts University
99
2
Kai‐Uwe Eckardt
Friedrich-Alexander-Universität Erlangen-Nürnberg
90
3
Rajnish Mehrotra
University of Washington
80
4
Michael B. Fallon
University of Arizona
80
5
Ravindra L. Mehta
University of California San Diego
70
6
Dimitrios T. Boumpas
National and Kapodistrian University of Athens
60
7
William M. Lee
The University of Texas Southwestern Medical Center
60
8
Carlo Brugnara
Boston Children's Hospital
50
9
Evangelos Terpos
National and Kapodistrian University of Athens
40
10
Pere Ginès
Universitat de Barcelona
30

All-Time Leaders Papers

1
Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury
Critical Care|2007
7.1k cit.
2
EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis
Journal of Hepatology|2018
2.8k cit.
3
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Annals of the Rheumatic Diseases|2019
2k cit.
4
Hematological findings and complications of <scp>COVID</scp>‐19
American Journal of Hematology|2020
1.7k cit.
5
Compensated cirrhosis: Natural history and prognostic factors
Hepatology|1987
1.1k cit.
6
Joint European League Against Rheumatism and European Renal Association–European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis
Annals of the Rheumatic Diseases|2012
1k cit.
7
Acute liver failure
Hepatology|2008
752 cit.
8
Statins: Old drugs as new therapy for liver diseases?
Journal of Hepatology|2018
165 cit.
9
Urine matrix metalloproteinase-7 and risk of kidney disease progression and mortality in type 2 diabetes
Journal of Diabetes and its Complications|2015
29 cit.
10
Investigating the Vascular Toxicity Outcomes of the Irreversible Proteasome Inhibitor Carfilzomib
International Journal of Molecular Sciences|2020
24 cit.

Reagents for dialysis and renal disease management

Citation-validated products used in this field

🔥 Trending

Gaining adoption fast

Cell Signaling Technology

Cleaved Caspase-3 (Asp175) (5A1E) Rabbit Monoclonal Antibody (BSA and Azide Free)

#94530$898
View Evidence →

⭐ Recommended

Best all-around

Cell Signaling Technology

Phospho-IRS-1 (Ser1101) Antibody

#2385$150
View Evidence →Cell Signaling Technology

Firefly Luciferase (E9W9V) Mouse Chimeric Monoclonal Antibody

#94817$155
View Evidence →Cell Signaling Technology

SMAD3 (C67H9) Rabbit Monoclonal Antibody

#9523$152
View Evidence →

🌟 All-Time

Most validated

Cell Signaling Technology

Cleaved-PARP (Asp214) (E2T4K) Mouse Monoclonal Antibody

#32563$179
View Evidence →Cell Signaling Technology

Phospho-IKK gamma (Ser376) Antibody

#2689$362
View Evidence →Cell Signaling Technology

Vimentin (D21H3) Rabbit Monoclonal Antibody (APC Conjugate)

#95159$465
View Evidence →